1. Home
  2. CMMB vs WOK Comparison

CMMB vs WOK Comparison

Compare CMMB & WOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CMMB
  • WOK
  • Stock Information
  • Founded
  • CMMB 2004
  • WOK 2002
  • Country
  • CMMB Israel
  • WOK China
  • Employees
  • CMMB N/A
  • WOK N/A
  • Industry
  • CMMB Biotechnology: Pharmaceutical Preparations
  • WOK
  • Sector
  • CMMB Health Care
  • WOK
  • Exchange
  • CMMB Nasdaq
  • WOK NYSE
  • Market Cap
  • CMMB 23.0M
  • WOK 20.2M
  • IPO Year
  • CMMB N/A
  • WOK 2024
  • Fundamental
  • Price
  • CMMB $1.19
  • WOK $0.71
  • Analyst Decision
  • CMMB Strong Buy
  • WOK
  • Analyst Count
  • CMMB 2
  • WOK 0
  • Target Price
  • CMMB $8.50
  • WOK N/A
  • AVG Volume (30 Days)
  • CMMB 211.9K
  • WOK 123.6K
  • Earning Date
  • CMMB 08-20-2025
  • WOK 02-03-2025
  • Dividend Yield
  • CMMB N/A
  • WOK N/A
  • EPS Growth
  • CMMB N/A
  • WOK N/A
  • EPS
  • CMMB N/A
  • WOK N/A
  • Revenue
  • CMMB N/A
  • WOK $11,506,440.00
  • Revenue This Year
  • CMMB N/A
  • WOK N/A
  • Revenue Next Year
  • CMMB N/A
  • WOK N/A
  • P/E Ratio
  • CMMB N/A
  • WOK N/A
  • Revenue Growth
  • CMMB N/A
  • WOK N/A
  • 52 Week Low
  • CMMB $0.87
  • WOK $0.36
  • 52 Week High
  • CMMB $2.55
  • WOK $8.45
  • Technical
  • Relative Strength Index (RSI)
  • CMMB 40.31
  • WOK N/A
  • Support Level
  • CMMB $1.17
  • WOK N/A
  • Resistance Level
  • CMMB $1.24
  • WOK N/A
  • Average True Range (ATR)
  • CMMB 0.07
  • WOK 0.00
  • MACD
  • CMMB -0.01
  • WOK 0.00
  • Stochastic Oscillator
  • CMMB 34.67
  • WOK 0.00

About CMMB Chemomab Therapeutics Ltd.

Chemomab Therapeutics Ltd is a clinical-stage biotech company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet needs. The company's candidate, CM-101, is a monoclonal antibody that targets CCL24 and was shown to interfere with the underlying biology of liver, skin, and lung fibrosis using a novel and differentiated mechanism of action. CM-101 has demonstrated the potential to treat multiple severe and life-threatening fibrotic and inflammatory diseases. It is advancing three Phase 2 clinical trials in parallel for CM-101, treating rare fibrotic conditions.

About WOK WORK MEDICAL TECHNOLOGY GROUP LTD

WORK Medical Technology Group Ltd is engaged in manufacturing and selling medical consumables through its wholly owned subsidiaries in the People's Republic of China. The Company's main products include medical face masks, tourniquets, airways, breathing circuits, intubation accessories, anesthesia kits, oxygen masks, suction sets, laryngoscope blades, KN95 masks, and other disposable medical devices, as well as medical equipment.

Share on Social Networks: